Abiopharma

Accelsius Announces General Availability of NeuCool® IR150 and Launches NeuCool HyperStart Program at Data Center World 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

(99% Neutral) NEOGEN CORP (NEOG) Announces Regulatory Update

Director Nelson Shawn David 🟢 acquired 1.5K shares of Lovesac Co (LOVE) at $16.95 Transaction Date: Apr 16, 2026 | Filing ID: 025915

ALTERITY THERAPEUTICS LTD (ATHE) Files Form 6-K

ALTERITY THERAPEUTICS LTD (ATHE) Files Form 6-K

HIGH TIDE INC. (HITI) Files Form 6-K

AECOM announces planned dates for second quarter fiscal 2026 earnings results and conference call

Ingles Markets Issues Open Letter to Shareholders

PRUDENTIAL PLC (PUK) Files Form 6-K

OBOOK HOLDINGS INC. (OWLS) Files Form 6-K

EQUINOR ASA (EQNR) Files Form 6-K

New Form ARS - Upland Software, Inc. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001505155-26-000025 <b>Size:</b> 26 MB

NOVO NORDISK A S (NVO) Files Form 6-K

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity